Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Caredx Inc (CDNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,104,123
  • Shares Outstanding, K 41,728
  • Annual Sales, $ 76,570 K
  • Annual Income, $ -46,760 K
  • 60-Month Beta 1.20
  • Price/Sales 14.52
  • Price/Cash Flow N/A
  • Price/Book 10.81

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.15
  • Number of Estimates 3
  • High Estimate -0.12
  • Low Estimate -0.17
  • Prior Year -0.16
  • Growth Rate Est. (year over year) +6.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.54 +3.60%
on 04/17/19
38.28 -30.89%
on 03/25/19
-10.46 (-28.33%)
since 03/22/19
3-Month
23.21 +14.00%
on 02/14/19
39.38 -32.81%
on 03/22/19
-0.82 (-3.01%)
since 01/24/19
52-Week
9.03 +193.02%
on 04/25/18
39.38 -32.81%
on 03/22/19
+17.11 (+182.99%)
since 04/24/18

Most Recent Stories

More News
CareDx to Announce First Quarter 2019 Financial Results on May 8th, 2019

CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on creating diagnostic solutions for organ transplant patients, today announced that it will release financial results for the...

CDNA : 26.46 (-0.71%)
CareDx Accuses Natera of False Advertising Claims That Mislead Medical Personnel and Transplant Patients

CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on creating diagnostic solutions for organ transplant patients, has filed a second lawsuit against Natera, Inc. in the United...

NTRA : 18.88 (-0.63%)
CDNA : 26.46 (-0.71%)
Cutting-Edge HeartCare and AlloMap Solutions Featured at ISHLT 2019

CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for transplant...

CDNA : 26.46 (-0.71%)
CareDx Files Patent Infringement Lawsuit Against Natera

CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant...

NTRA : 18.88 (-0.63%)
CDNA : 26.46 (-0.71%)
Market Trends Toward New Normal in Louisiana-Pacific, The Michaels Companies, VEREIT, CymaBay Therapeutics, CareDx, and Harsco -- Emerging Consolidated Expectations, Analyst Ratings

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Louisiana-Pacific Corporation...

VER : 8.21 (+0.86%)
LPX : 24.08 (+0.29%)
CBAY : 12.72 (+2.00%)
HSC : 22.57 (-0.79%)
CDNA : 26.46 (-0.71%)
MIK : 12.84 (+1.74%)
Cedars Sinai Uses AlloSure in Tocilizumab Trial

CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients,...

CDNA : 26.46 (-0.71%)
AlloSure Heart Clinical Validation Published in Leading Transplant Journal

CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for transplant...

CDNA : 26.46 (-0.71%)
CareDx (CDNA) in Focus: Stock Moves 9.8% Higher

CareDx (CDNA) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.

BEAT : 58.73 (+0.27%)
CDNA : 26.46 (-0.71%)
CareDx Reports Fourth Quarter and FY 2018 Results

CareDx, Inc. (NASDAQ: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients,...

CDNA : 26.46 (-0.71%)
CareDx Welcomes Initiatives from US Government to Support Transplant Care

CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients,...

CDNA : 26.46 (-0.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade CDNA with:

Business Summary

CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of...

See More

Key Turning Points

2nd Resistance Point 27.50
1st Resistance Point 26.98
Last Price 26.46
1st Support Level 25.89
2nd Support Level 25.32

See More

52-Week High 39.38
Fibonacci 61.8% 27.79
Last Price 26.46
Fibonacci 50% 24.20
Fibonacci 38.2% 20.62
52-Week Low 9.03

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar